HOME >> BIOLOGY >> NEWS
Stem cell specialists face questioning

A top panel of experts will face questions of public and scientific concern on stem cell research during an international conference being held at The University of Manchester this week.

The Stem Cell Question Time will be headed by Lord Naren Patel, chair of the UK National Stem Cell Network, as part of Stem Cell Manchester, a three-day gathering of stem cell researchers from across the globe.

Among the panellists at Wednesdays event will be Ron McKay from the National Institutes of Health, Bethesda, USA, Justine Burley, from the University of Singapore, and Jed Davies, from the University of Toronto, Canada.

The audience, which will be comprised of scientists both within and outside the field, will be invited to submit questions on important, contentious and challenging issues facing the stem cell research community.

Such topics up for discussion are likely to focus on the ethical issues surrounding stem cell research as well as the scientific challenges that must be overcome if this cutting-edge branch of biomedical research is to fulfil its true potential.

Also on the panel are Alan Coleman, from Embryonic Stem Cell International, Singapore, Chris Mason, from University College, London, and Daniel Brison, Co-director of the Northwest Embryonic Stem Cell Research Centre based at St Marys Hospital and The University of Manchester.

The Stem Cell Manchester conference has attracted leading figures in stem cell research from across the world, said organiser Professor Tim Hardingham, who is based in Manchesters Faculty of Life Sciences.

We have a packed programme of speakers lined up over the next few days culminating with the Question Time event on Wednesday where people outside the field can take part in a full and frank debate of the issues surrounding stem cell research.

Among the speakers at the conference is Shinya Yamanaka, whose team at Kyoto University in Japan is pioneering wa
'"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
16-Jul-2007


Page: 1 2

Related biology news :

1. Heart specialists call for cardiovascular screening for all young competitive athletes
2. Bone specialists hi-tech answer to patient care
3. NNii media advisory about David Kirbys book questioning vaccine safety

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stem cell specialists face questioning

(Date:7/31/2014)... Census Bureau, Latinos are the largest minority group in ... Approximately one-third of Latinos are obese and are 1.2 ... Whites. , NYU College of Nursing student researcher ... identify the factors that contribute to this problem by ... on food patterns in Latina women recently published in ...
(Date:7/31/2014)... of the roughly 156,000 gas stations across the ... parts of underground gas storage tankscorrosion that could ... a source of drinking water. In recent years, ... rapidly corroding gas storage tank components such as ... use of gasoline-ethanol blends and the presence of ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2NIST corrosion lab tests suggest need for underground gas tank retrofits 2C. difficile vaccine proves safe, 100 percent effective in animal models 2
(Date:7/31/2014)... The global market for molecular diagnostics is expected to ... new study by Grand View Research, Inc. Growing demand ... of advanced cancer diagnostic technologies are expected to be ... years. Moreover, the growing global base of geriatric population ... triggering lifestyle habits such as smoking and excessive alcohol ...
(Date:7/31/2014)... 31, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues, today ... results will be released on Thursday, August 7, 2014, ... and live webcast at 4:30 p.m. ET that afternoon. ...
(Date:7/31/2014)... July 31, 2014 Boston’s Adult Stem ... flush with innovative adult stem cell biotechnologies. Currently ... and has three additional patent applications currently under examination ... patented inventions address two of the most vexing problems ... Adult stem cells are difficult to identify; and ...
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... today announced that the Companies intend to use a ... priority review voucher in connection with the Biologics License ... entitles the holder to designate a BLA for priority ... the filing date instead of the standard 10-month review. ...
Breaking Biology Technology:Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6
Cached News: